Asia On The Move: CFDA Names New Drug Review Director, Shionogi Reorgs R&D
This article was originally published in PharmAsia News
Executive Summary
China’s Center for Drug Evaluation gets a new director; Japanese pharma Shionogi reorganizes R&D and plans to establish R&D centers in China and Europe. Changes also took place at AstraZeneca in Japan and Cipla and Sun Pharma in India.